--Hewlett Packard to Get EU Approval for $14 Billion Juniper Networks Acquisition, Reuters Reports-September 2024-www.financetom.com

--Hewlett Packard to Get EU Approval for $14 Billion Juniper Networks Acquisition, Reuters Reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Hewlett Packard to Get EU Approval for $14 Billion Juniper Networks Acquisition, Reuters Reports

Jul 29, 2024 7:20 AM

09:54 AM EDT, 07/29/2024 (MT Newswires) --

Price: 19.64, Change: -0.13, Percent Change: -0.63

Previous page： --Hewlett Packard to Get EU Approval for $14 Billion Juniper Networks Acquisition, Reuters Reports Next page： Cannabix Up 18% After Saying in "Advanced" Talks to Distribute Breath Logix Device in Texas

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Hewlett Packard to Get EU Approval for $14 Billion Juniper Networks Acquisition, Reuters Reports

Jul 29, 2024

09:54 AM EDT, 07/29/2024 (MT Newswires) -- Price: 19.64, Change: -0.13, Percent Change: -0.63 ...

Cannabix Up 18% After Saying in "Advanced" Talks to Distribute Breath Logix Device in Texas

Jul 29, 2024

09:59 AM EDT, 07/29/2024 (MT Newswires) -- Cannabix Technologies ( BLOZF ) , which is up 18% to $0.58 at last look, has begun discussions with Smartox of Irving, Texas for the potential sales distribution of its Breath Logix Alcohol screening device. Cannabix ( BLOZF ) has shipped its device for evaluation, preliminary marketing and business development purposes. Cannabix (...

GSK Partners With Flagship Pioneering to Develop New Respiratory, Immunology Therapies

Jul 29, 2024

09:54 AM EDT, 07/29/2024 (MT Newswires) -- GSK (GSK) is partnering with bioplatform company Flagship Pioneering to identify and develop new medicines and vaccines, starting with prospective respiratory and immunology treatments, Flagship said Monday. The deal calls for GSK and Flagship to put $150 million toward an exploratory phase that would identify the ten most promising prospective medicines and vaccines...

Cyclo Therapeutics to Receive European Patent for Alzheimer's Disease Treatment

Jul 29, 2024

09:54 AM EDT, 07/29/2024 (MT Newswires) -- Cyclo Therapeutics ( CYTH ) said Monday it has been notified by the European Patent Office that it will be granted a European patent for its method of treating Alzheimer's disease. The decision will be published on Aug. 21 and the patent will take effect on that date, the company said. Shares of...